SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-000120
Filing Date
2023-02-14
Accepted
2023-02-14 16:05:56
Documents
51
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20221231x10q.htm   iXBRL 10-Q 850044
2 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 12328
3 EX-31.2 tmb-20221231xex31d2.htm EX-31.2 13416
4 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 8173
  Complete submission text file 0001410578-23-000120.txt   3902597

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20221231.xsd EX-101.SCH 28788
6 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 36519
7 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 93726
8 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 293871
9 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 197051
45 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10q_htm.xml XML 607624
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 23628815
SIC: 2834 Pharmaceutical Preparations